David Liebowitz - Concepedia

Author

David Liebowitz

University of Chicago

Also Known As

David Liebowitz, David N Liebowitz, David N. Liebowitz, David Neal Liebowitz, Liebowitz, David

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

University of Chicago Vaxart (United States)The University of Texas MD Anderson Cancer Center Xencor (United States)WinnMed

About

David Liebowitz is an author at University of Chicago specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	1.7K
2	Cell Biology	3	3	1.3K
3	Health Sciences	1	1	47
4	Public Health	1	1	109
5	Cellular Physiology	1	1	1.3K

David Liebowitz

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells David Wang, David Liebowitz, Elliott Kieff Cell Molecular VirologyCell SignalingRodent CellsImmunologyViral Pathogenesis	1985	1.3K
Epstein–Barr Virus and a Cellular Signaling Pathway in Lymphomas from Immunosuppressed Patients David Liebowitz New England Journal of Medicine	1998	231
Flavopiridol, A Novel Cyclin-Dependent Kinase Inhibitor, in Metastatic Renal Cancer: A University of Chicago Phase II Consortium Study Walter M. Stadler, Nicholas J. Vogelzang, Robert J. Amato, Journal of Clinical Oncology	2000	208
Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation Ginna G. Laport, Bruce L. Levine, Edward A. Stadtmauer, Blood	2003	178
Safety and immunogenicity of an oral tablet norovirus vaccine, a phase I randomized, placebo-controlled trial Leesun Kim, David Liebowitz, Karen Lin, JCI Insight	2018	132
Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study David Liebowitz, Keith Gottlieb, Nikita Kolhatkar, The Lancet Infectious Diseases VaccinationVaccine SafetyCross-protectionOral Influenza VaccineHuman Challenge Study	2020	109
High titre neutralising antibodies to influenza after oral tablet immunisation: a phase 1, randomised, placebo-controlled trial David Liebowitz, Jonathan D. Lindbloom, Jennifer R. Brandl, The Lancet Infectious Diseases VaccinationVaccine DevelopmentImmunologyHigh TitreVaccine Efficacy	2015	88
In vitro evaluation of flavopiridol, a novel cell cycle inhibitor, in bladder cancer Mark Chien, Mary Astumian, David Liebowitz, Cancer Chemotherapy and Pharmacology UrologyOncologyGenitourinary CancerMedicinePharmacotherapy	1999	49
An Epstein-Barr Virus Transforming Protein Associates with Vimentin in Lymphocytes David Liebowitz, Raphael Kopan, Elaine Fuchs, Molecular and Cellular Biology Molecular VirologyEpstein-barr VirusVimentin-associated ProteinPathogenesisViral Pathogenesis	1987	48
Hematopoietic Expression of Hoxb4 Is Regulated in Normal and Leukemic Stem Cells through Transcriptional Activation of the Hoxb4 Promoter by Upstream Stimulating Factor (Usf)-1 and Usf-2 Diane Giannola, Warren D. Shlomchik, M Jegathesan, The Journal of Experimental Medicine Hoxb4 ExpressionTranscriptional RegulationStem Cell MobilizationStem Cell TransplantationHematology	2000	47

Page 1